


Healthcare News Roundup: Ophthalmology
HSMN NewsFeed - 4 Aug 2009
Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
Oraya Therapeutics Names Jim Taylor as President and Chief Executive Officer
HSMN NewsFeed - 30 Jul 2009
Second Phase III Study Showed Lucentis Improved Vision in Patients With Retinal Vein Occlusion
Second Phase III Study Showed Lucentis Improved Vision in Patients With Retinal Vein Occlusion
